This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: BriaCell Therapeutics Corp.
Is presenting positive data from its preclinical Bria-OTS+ platform at the 2026 American Association for Cancer Research (AACR) Annual Meeting taking place at the San Diego Convention Center in San Diego until Wednesday. BriaCell Therapeutics Corp. shares T.BCT are trading down $0.07 at $5.42.
